FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | Sample | Privacy

P&G labeling missteps garner warning

Procter & Gamble has been cited for the illegal marketing of combinations of dietary ingredients and drugs.

P&G products Vicks DayQuil Plus Vitamin C and Vicks Nyquil Plus Vitamin C lack proof of safety and efficacy, the regulator says, citing lack of scientific evidence linking vitamin C to the prevention and treatment of colds.

In addition, labeling on the two over-the-counter medicines incorrectly identifies acetaminophen, detromethorphan HBr, and phenylephrine HCl or doxylamine succinate as "other ingredients" as well as active drug ingredients; vitamin C was identified as both an inactive and active ingredient.

Corrective steps response deadline under the tougher FDA: within 15 days of the October 29, 2009, warning latter date.

- here's the article
- see the warning letter

Related Articles:
Warner Chilcott pays $3.1B for P&G drug unit
P&G plots sale of pharma brands


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Manufacturing Email Newsletter:
Be the first to comment
More stories about Warning Letter   Corrective Steps   Response Deadline   labeling   Procter & Gamble  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.